Retrospective Cohort Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Sep 14, 2015; 21(34): 9957-9965
Published online Sep 14, 2015. doi: 10.3748/wjg.v21.i34.9957
Table 3 Comparisons of the baseline characteristics between lamivudine plus adefovir and entecavir treated patients
CharacteristicLAM + ADVETVP value
(n = 20)(n = 13)
Age (yr)29.5 (23.0-47.8)24.0 (22.4-41.8)0.158
Sex (male/female)17/310/30.659
HBV DNA (log10 copies/mL)7.25 (5.96-7.98)7.56 (6.02-8.44)0.334
ALT (ULN)3.59 (1.66-16.56)3.12 (1.79-17.23)0.548
GGT (ULN)1.01 (0.60-2.55)0.76 (0.33-2.55)0.137